michael a beazely
University of Waterloo
Waterloo, Canada
Associate Editor
Neuropharmacology
University of Waterloo
Waterloo, Canada
Associate Editor
Neuropharmacology
Novartis Institutes for BioMedical Research
Basel, Switzerland
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
University of Poitiers
Poitiers, France
Associate Editor
Pharmacology of Ion Channels and Channelopathies
Mayo Clinic
Rochester, United States
Associate Editor
Integrative and Regenerative Pharmacology
Department of Medical Biochemistry, Molecular Biology, Faculty of Medicine, University of Seville
Seville, Spain
Associate Editor
Experimental Pharmacology and Drug Discovery
University of RibeirĂŁo Preto
RibeirĂŁo Preto, Brazil
Associate Editor
Neuropharmacology
Department of Psychiatry, School of Medicine, Indiana University Bloomington
Suite, United States
Associate Editor
Neuropharmacology
University of Foggia
Foggia, Italy
Associate Editor
Neuropharmacology
University of Pisa
Pisa, Italy
Associate Editor
Gastrointestinal and Hepatic Pharmacology
Leiden University
Leiden, Netherlands
Associate Editor
Predictive Toxicology
University College Dublin
Dublin, Ireland
Associate Editor
Inflammation Pharmacology
Biotechnology Institute, Ankara University
Ankara, TĂĽrkiye
Associate Editor
Experimental Pharmacology and Drug Discovery
Department of Gastroenterology, Krankenhaus GmbH Weilheim - Schongau
Weilheim - Schongau, Germany
Associate Editor
Gastrointestinal and Hepatic Pharmacology
University of Turin
Turin, Italy
Associate Editor
Inflammation Pharmacology
NeuroCODE - Neurophysiology of Cognition & CNS Development Laboratory, Department of Physiology, Institute of Basic and Health Science (ICBS), Federal University of Rio Grande do Sul (UFRGS)
Porto Alegre, Brazil
Associate Editor
Neuropharmacology
Mario Negri Institute for Pharmacological Research (IRCCS)
Milano, Italy
Associate Editor
Predictive Toxicology